33720890|t|Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
33720890|a|BACKGROUND: Longitudinal changes in cerebrospinal fluid (CSF) biomarkers are seldom studied. Furthermore, data on biomarker gradient between lumbar (L-) and ventricular (V-) compartments seems to be discordant. OBJECTIVE: To examine alteration of CSF biomarkers reflecting Alzheimer's disease (AD)-related amyloid-beta (Abeta) aggregation, tau pathology, neurodegeneration, and early synaptic degeneration by CSF shunt surgery in idiopathic normal pressure hydrocephalus (iNPH) in relation to AD-related changes in brain biopsy. In addition, biomarker levels in L- and V-CSF were compared. METHODS: L-CSF was collected prior to shunt placement and, together with V-CSF, 3-73 months after surgery. Thereafter, additional CSF sampling took place at 3, 6, and 18 months after the baseline sample from 26 iNPH patients with confirmed Abeta plaques in frontal cortical brain biopsy and 13 iNPH patients without Abeta pathology. CSF Amyloid-beta42 (Abeta42), total tau (T-tau), phosphorylated tau (P-tau181), neurofilament light (NFL), and neurogranin (NRGN) were analyzed with customized ELISAs. RESULTS: All biomarkers but Abeta42 increased notably by 140-810% in L-CSF after CSF diversion and then stabilized. Abeta42 instead showed divergent longitudinal decrease between Abeta-positive and -negative patients in L-CSF, and thereafter increase in Abeta-negative iNPH patients in both L- and V-CSF. All five biomarkers correlated highly between V-CSF and L-CSF (Abeta42 R = 0.87, T-tau R = 0.83, P-tau R = 0.92, NFL R = 0.94, NRGN R = 0.9; all p < 0.0001) but were systematically lower in V-CSF (Abeta42 14 %, T-tau 22%, P-tau 20%, NFL 32%, NRGN 19%). With APOE genotype-grouping, only Abeta42 showed higher concentration in non-carriers of allele e4. CONCLUSION: Longitudinal follow up shows that after an initial post-surgery increase, T-tau, P-tau, and NRGN are stable in iNPH patients regardless of brain biopsy Abeta pathology, while NFL normalized toward its pre-shunt levels. Abeta42 as biomarker seems to be the least affected by the surgical procedure or shunt and may be the best predictor of AD risk in iNPH patients. All biomarker concentrations were lower in V- than L-CSF yet showing strong correlations.
33720890	49	66	Neurodegeneration	Disease	MESH:D019636
33720890	70	110	Idiopathic Normal Pressure Hydrocephalus	Disease	MESH:D006850
33720890	385	404	Alzheimer's disease	Disease	MESH:D000544
33720890	406	408	AD	Disease	MESH:D000544
33720890	418	430	amyloid-beta	Gene	351
33720890	432	437	Abeta	Gene	351
33720890	452	455	tau	Gene	4137
33720890	467	484	neurodegeneration	Disease	MESH:D019636
33720890	496	517	synaptic degeneration	Disease	MESH:D012183
33720890	542	582	idiopathic normal pressure hydrocephalus	Disease	MESH:D006850
33720890	584	588	iNPH	Disease	MESH:D006850
33720890	605	607	AD	Disease	MESH:D000544
33720890	674	675	L	Chemical	MESH:D007930
33720890	681	686	V-CSF	Chemical	-
33720890	711	716	L-CSF	Chemical	-
33720890	775	780	V-CSF	Chemical	-
33720890	913	917	iNPH	Disease	MESH:D006850
33720890	918	926	patients	Species	9606
33720890	942	947	Abeta	Gene	351
33720890	996	1000	iNPH	Disease	MESH:D006850
33720890	1001	1009	patients	Species	9606
33720890	1018	1023	Abeta	Gene	351
33720890	1055	1062	Abeta42	Gene	351
33720890	1071	1074	tau	Gene	4137
33720890	1099	1102	tau	Gene	4137
33720890	1115	1134	neurofilament light	Gene	4747
33720890	1136	1139	NFL	Gene	4747
33720890	1146	1157	neurogranin	Gene	4900
33720890	1159	1163	NRGN	Gene	4900
33720890	1231	1238	Abeta42	Gene	351
33720890	1272	1277	L-CSF	Chemical	-
33720890	1319	1326	Abeta42	Gene	351
33720890	1382	1387	Abeta	Gene	351
33720890	1411	1419	patients	Species	9606
33720890	1423	1428	L-CSF	Chemical	-
33720890	1457	1462	Abeta	Gene	351
33720890	1472	1476	iNPH	Disease	MESH:D006850
33720890	1477	1485	patients	Species	9606
33720890	1501	1506	V-CSF	Chemical	-
33720890	1554	1559	V-CSF	Chemical	-
33720890	1564	1569	L-CSF	Chemical	-
33720890	1571	1578	Abeta42	Gene	351
33720890	1621	1624	NFL	Gene	4747
33720890	1635	1639	NRGN	Gene	4900
33720890	1698	1703	V-CSF	Chemical	-
33720890	1705	1712	Abeta42	Gene	351
33720890	1741	1744	NFL	Gene	4747
33720890	1750	1754	NRGN	Gene	4900
33720890	1766	1770	APOE	Gene	348
33720890	1795	1802	Abeta42	Gene	351
33720890	1965	1969	NRGN	Gene	4900
33720890	1984	1988	iNPH	Disease	MESH:D006850
33720890	1989	1997	patients	Species	9606
33720890	2025	2030	Abeta	Gene	351
33720890	2048	2051	NFL	Gene	4747
33720890	2092	2099	Abeta42	Gene	351
33720890	2212	2214	AD	Disease	MESH:D000544
33720890	2223	2227	iNPH	Disease	MESH:D006850
33720890	2228	2236	patients	Species	9606
33720890	2281	2282	V	Chemical	MESH:D014639
33720890	2289	2294	L-CSF	Chemical	-
33720890	Association	348	351
33720890	Association	MESH:D006850	351
33720890	Association	MESH:D000544	351
33720890	Association	MESH:D006850	348
33720890	Association	MESH:D019636	351
33720890	Association	MESH:D014639	351

